LUPIN LIMITED Share Price & Technical Analysis
LUPIN · ₹2,414 (-0.21%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹2,414
-0.21%
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It produces, develops, and markets various branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company also offers products in the therapeutic a…
Price chart
Seasonality
Aug has 3 positive and 1 negative years (last 5 years shown)
13% return in 2026, 37% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 2% | 8% | 2% | -2% | -2% | 6% | -1% | – | – | – | – | – | 13% |
| 25 | -12% | -7% | 7% | 4% | -6% | -1% | -1% | -2% | 1% | 2% | 6% | 1% | -8% |
| 24 | 14% | 7% | 0% | 0% | -4% | 0% | 18% | 17% | -3% | 0% | -7% | 15% | 57% |
| 23 | 0% | -11% | -1% | 9% | 13% | 12% | 9% | 11% | 7% | -4% | 13% | 3% | 63% |
| 22 | -5% | -19% | 1% | 0% | -16% | -2% | 5% | 3% | 2% | 3% | 9% | -4% | -23% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Uptrend · Neutral
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It produces, develops, and markets various branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company also offers products in the therapeutic areas of cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infectives, anti-TB, cephalosporins, and nonsteroidal anti-inflammatory drug therapies. In addition, it provides chronic therapies, and hospital-based products; products for diabetes and iron supplements for anemia, and a Budesonide-Formoterol combination for asthma. Further, the company is involved in the provision of diagnostics services, and digital healthcare services; and neuro rehabilition business. It operates through network consisting of labs and collection centers. The company has a strategic collaboration with TB Alliance to support the clinical development and commercialization of Telacebec for the treatment of tuberculosis, leprosy, and buruli ulcer. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹1.10T
P/E ratio
20.74
52W high
₹2,434
52W low
₹1,774
Volume
30,934
Beta
0.18
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹3,274
Frequently asked questions
- What is LUPIN LIMITED share price today?
- LUPIN LIMITED (LUPIN) last traded around ₹2,414 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does LUPIN have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for LUPIN. Download the app for real-time alerts.
- How can I analyze LUPIN LIMITED stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.